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Abstract 
Motivation: Very low depth sequencing has been proposed as a cost-effective approach to capture 
low-frequency and rare variation in complex trait association studies. However, a full characterisation 
of the genotype quality and association power for very low depth sequencing designs is still lacking. 
Results: We perform cohort-wide whole genome sequencing (WGS) at low depth in 1,239 individuals 
(990 at 1x depth and 249 at 4x depth) from an isolated population, and establish a robust pipeline for 
calling and imputing very low depth WGS genotypes from standard bioinformatics tools. Using geno-
typing chip, whole-exome sequencing (WES, 75x depth) and high-depth (22x) WGS data in the same 
samples, we examine in detail the sensitivity of this approach, and show that imputed 1x WGS recapit-
ulates 95.2% of variants found by imputed GWAS with an average minor allele concordance of 97% 
for common and low-frequency variants. In our study, 1x further allowed the discovery of 140,844 true 
low-frequency variants with 73% genotype concordance when compared to high-depth WGS data. Fi-
nally, using association results for 57 quantitative traits, we show that very low depth WGS is an efficient 
alternative to imputed GWAS chip designs, allowing the discovery of up to twice as many true associ-
ation signals than the classical imputed GWAS design. 
Availability: The HELIC genotype and WGS datasets have been deposited to the European Genome-
phenome Archive (https://www.ebi.ac.uk/ega/home): EGAD00010000518; EGAD00010000522; 
EGAD00010000610; EGAD00001001636, EGAD00001001637. The peakplotter software is available 
at https://github.com/wtsi-team144/peakplotter, the transformPhenotype app can be downloaded at 
https://github.com/wtsi-team144/transformPhenotype. 
Contact: eleftheria.zeggini@helmholtz-muenchen.de  
Supplementary information: Supplementary data are available at Bioinformatics online. 
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1 Introduction  
The contribution of low-frequency and rare variants to the allelic architec-
ture of complex traits remains largely uncharted. Power to detect associa-
tion is central to genetic studies examining sequence variants across the 
full allele frequency spectrum. Whole genome sequencing (WGS)-based 
association studies hold the promise of probing a larger proportion of se-
quence variation compared to imputed genome-wide genotyping arrays. 
However, although large-scale high-depth WGS efforts are now underway 
(Brody, et al., 2017), comparatively high costs do not yet allow for the 
generalised transposition of the GWAS paradigm to high-depth sequenc-
ing. As sample size and haplotype diversity are more important than se-
quencing depth in determining power for association studies (Alex 
Buerkle and Gompert, 2013; Le and Durbin, 2011), low-depth WGS has 
emerged as an alternative, cost-efficient approach to capture low-fre-
quency variation in large studies. Improvements in calling algorithms have 
enabled robust genotyping using WGS at low depth (4x-8x), leading to the 
creation of large haplotype reference panels (1000 Genomes Project Con-
sortium, et al., 2015; McCarthy, et al., 2016), and to several low-depth 
WGS-based association studies (Astle, et al., 2016; Tachmazidou, et al., 
2017; UK10K Consortium, et al., 2015). Very low depth (<2x) sequencing 
has been proposed as an efficient way to further improve the cost effi-
ciency of sequencing-based association studies. Simulations have shown 
that in WES designs, extremely low sequencing depths (0.1-0.5x) are ef-
fective in capturing single-nucleotide variants (SNVs) in the common 
(MAF>5%) and low-frequency (MAF 1-5%) categories compared to im-
puted GWAS arrays (Pasaniuc, et al., 2012). The CONVERGE consor-
tium demonstrated the feasibility of such approaches through the first suc-
cessful case-control study of major depressive disorder in 4,509 cases and 
5,337 controls (Converge Consortium, 2015), and we previously showed 
that 1x WGS allowed the discovery of burdens of low-frequency and rare 
variants that replicate in cosmopolitan and diverse populations (Gilly, et 
al., 2016). However, a systematic examination of genotyping quality from 
1x WGS and its implications for power in association studies is lacking, 
posing the question of the generalisability of such results in the wider con-
text of next-generation association studies. Here, we perform very low 
depth (1x), cohort-wide WGS in an isolated population from Greece, show 
that imputation tools commonly used with chip data perform well using 
1x WGS,  and establish a detailed quality profile of called variants. We 
then demonstrate the advantages of 1x WGS compared to the more tradi-
tional imputed GWAS design both in terms of genotype accuracy and 
power to detect association signals. 
2 Results 
As part of the Hellenic Isolated Cohorts (HELIC) study, we whole genome 
sequenced 990 individuals from the Minoan Isolates (HELIC-MANOLIS) 
cohort at 1x depth, on the Illumina HiSeq2000 platform. In addition, 249 
samples from the MANOLIS cohort were sequenced at 4x depth 
(Southam, et al., 2017). Imputation-based genotype refinement was per-
formed on the cohort-wide dataset using a combined reference panel of 
10,244 haplotypes from MANOLIS 4x WGS, the 1000 Genomes (1000 
Genomes Project Consortium, et al., 2015) and UK10K (UK10K Consor-
tium, et al., 2015) projects (Figure 1). 
2.1 Variant calling pipeline 
Prior to any imputation-based refinement, our approach allowed the cap-
ture of 80% and 100% of low-frequency (MAF 1-5%) and common 
(MAF>5%) SNVs, respectively, when compared to variants present on the 
Illumina OmniExpress and HumanExome chips genotyped in the same 
samples. In 10 control samples from the Platinum Genomes dataset 
(Eberle, et al., 2017) with high-depth WGS data (50x) downsampled to 
1x, joint calling with MANOLIS resulted in pre-imputation false positive 
and false negative rates of 12% and 24.6%, respectively (See Methods).  
In order to improve sensitivity and genotype accuracy, we compared thir-
teen genotype refinement and imputation pipelines using tools commonly 
used for genotyping chip imputation, using directly typed OmniExpress 
a.
b.
Figure 1: Processing pipeline for the MANOLIS 1x data. Tools and parameters for the 
genotype refinement and phasing steps were selected after benchmarking thirteen pipelines 
involving four different tools (See Methods). 
 
Figure 2: Concordance and call rate for low depth WGS genotypes. a. Genotype (blue 
circles) and minor allele (yellow circles) concordance is computed for 1,239 samples in 
MANOLIS (4x and 1x) against merged OmniExpress and ExomeChip data. Call rate is as-
sessed for the refined (purple) and refined plus imputed (green) datasets. b. Non-reference 
allele concordance (green circles) and positive predictive value (PPV) (fuchsia bars) is com-
puted for 1,127 MANOLIS samples with both 22x WGS and low-depth calls. 
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and ExomeChip genotypes as a benchmark (See Methods). We used a ref-
erence panel containing haplotypes from 4,873 cosmopolitan samples 
from the 1000 Genomes and UK10K projects, as well as the phased hap-
lotypes from 249 MANOLIS samples sequenced at 4x depth. The best-
performing pipeline, described in Figure 1, captures 95% of rare, 99.7% 
of low-frequency and 99.9% of common variants present in chip data, with 
an average minor allele concordance of 97% across the allele frequency 
spectrum (see Methods, Figure 2a., Supplementary Figure 1, Supplemen-
tary Table 1). 79.7% of 1x WGS variants were found using high-depth 
WGS at 22x in a subset of the MANOLIS samples (n=1,127), although 
this positive predictive value varied across the MAF spectrum, from 8.9% 
for singletons to 95.1% for common variants (Figure 2b.). Genotype con-
cordance was similar, although slightly lower, when compared to the chip 
variants. Due to the 22x data being aligned to a different build and the 
unmappable regions resulting from a lift-over, we were unable to compute 
genome-wide false positive rates, however by comparing 1x calls with 
those produced by whole-exome sequencing in 5 individuals from the 
MANOLIS cohort, we estimate a false-positive rate of 2.4% post-imputa-
tion in the coding parts of the genome (see Methods).  
2.2 Comparison of variant call sets with an imputed GWAS 
The genotype refinement and imputation step yielded 30,483,136 non-
monomorphic SNVs in 1,239 MANOLIS individuals. The number of var-
iants discovered using 1x WGS is nearly twice as high as that from array-
based approaches. In a subset of 982 MANOLIS individuals with both 1x 
WGS, OmniExpress and ExomeChip data, we called 25,673,116 non-
monomorphic SNVs using 1x WGS data, compared to 13,078,518 non-
monomorphic SNVs in the same samples with chip data imputed up to the 
same panel (Southam, et al., 2017) without any imputation INFO score 
filtering. The main differences are among rare variants (MAF<1%) (Fig-
ure 3):  13,671,225 (53.2%) variants called in the refined 1x WGS are 
absent from the imputed GWAS, 98% of which are rare. 82% of these rare 
unique SNVs are singletons or doubletons, and therefore 9.5% of all vari-
ants called in the 1x WGS dataset were unique variants with MAC>2.  
A crucial question is the proportion of true positives among these addi-
tional SNVs not found by GWAS and imputation. By comparing their po-
sitions and alleles with high-depth WGS in the same samples, we find that 
the PPV profile for these variants is much lower compared to when all 
variants are examined (Figure 4 and Figure 2.b). As expected, PPV is al-
most zero for additional singletons and doubletons, and just above 40% 
for the few additional common variants. 62% of low-frequency variants 
unique to the 1x are true positives, which corresponds to 140,844 low-
frequency variants with high genotyping quality that are missed by the 
imputed GWAS. Minor allele concordance is lower than for all variants, 
with a lower bound at 55% for rare variants and reaching 73% for novel 
low-frequency variants. 
2.3 Comparison of association summary statistics with im-
puted GWAS 
1x WGS calls a larger number of variants and is noisier than imputed 
GWAS in the same samples. To evaluate how this difference affects asso-
ciation study power, we performed genome-wide association of 57 quan-
titative traits in 1,225 overlapping samples with both imputed OmniEx-
ome and 1x WGS using both sources of genotype data. We then compared 
independent suggestively associated signals at p<5x10-7 (Supplementary 
Table 2). These signals were then cross-referenced with a larger (n=1,457) 
study based on 22x WGS on the same traits in the same cohort (Gilly, et 
al., 2018). We only considered signals to be true if they displayed evidence 
for association with at most a two order of magnitude attenuation com-
pared to our suggestive significance threshold (P<5x10-5). According to 
Figure 4: Frequency and positive predictive value of variants in 1x sequencing not found 
by GWAS and imputation. 1x variants not found in the GWAS data, arranged by MAF bin, 
in raw numbers (top). Green bars count variants recapitulated in the 22x (true positives). The 
proportion of these over the total (positive predictive value) is displayed in each bin in the 
bottom panel. The black line indicates minor allele concordance for true positive variants. 
The first category (0-0.1%) contains singletons and doubletons only. 
Figure 3: Unique variants called by sequencing and imputed GWAS. Variants unique 
to either dataset, arranged by MAF bin. Both datasets are unfiltered apart from monomor-
phics, which are excluded. MAF categories: rare (MAF<1%), low-frequency (MAF 1-5%), 
common (MAF>5%).  
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this metric, 52 of 182 independent signals (28.5%) were true in the im-
puted GWAS, in contrast to 108 of 462 (23.4%) in the 1x study (Figure 
5). With an equal sample size and identically transformed traits, 1x there-
fore allowed to discover twice as many independent GWAS signals with 
almost identical truth sensitivity. Seven rare and three suggestive low-fre-
quency variant associations in the 1x WGS data (9.2% of all signals) were 
driven by a variant not present and without a tagging SNP at r2>0.8 in the 
imputed GWAS, whereas the converse is true for only two rare variants in 
the imputed GWAS. Among variants called or tagged in the imputed 
GWAS, 4 rare, 11 low-frequency and 5 common SNV associations de-
tected in the 1x (19% of total) are not seen associated below that threshold 
in the imputed GWAS. As expected, there are significantly fewer (3.8%, 
P=0.01, one-sided chi-square proportion test) true associations in the im-
puted GWAS not recapitulated by the 1x study.  
3 Discussion 
In this work, we empirically demonstrate the relative merits of very low 
depth WGS both in terms of variant discovery and association study power 
for complex quantitative traits compared to GWAS approaches. However, 
the advantages of 1x WGS have to be weighed against compute and finan-
cial cost considerations. As of summer 2018, 1x WGS on the HiSeq 4000 
platform was approximately half of the cost of a dense GWAS array (e.g. 
Illumina Infinium Omni 2.5Exome-8 array), the same cost as a sparser 
chip such as the Illumina HumanCoreExome array, and half of the cost of 
WES at 50x depth. By comparison, 30x WGS was 23 or 15 times more 
costly depending on the sequencing platform (Illumina HiSeq 4000 or 
HiSeqX, respectively). The number of variants called by 1x WGS is lower 
than high-depth WGS, but is in the same order of magnitude, suggesting 
comparable disk storage requirements for variant calls. However, storage 
of the reads required an average 650Mb per sample for CRAMs, and 
1.3Gb per sample for BAMs.  
 
Genome-wide refinement and imputation of very low depth WGS gener-
ates close to 50 times more variants than a GWAS chip. The complexity 
of the imputation and phasing algorithms used in this study is linear in the 
number of markers, linear in the number of target samples and quadratic 
in the number of reference samples (Browning and Browning, 2016), 
which results in a 50-fold increase in total processing time compared to an 
imputed GWAS study of equal sample size. In MANOLIS the genome 
was divided in 13,276 chunks containing equal number of SNVs, which 
took an average of 31 hours each to refine and impute. The total processing 
time was 47 core-years (see Methods and Supplementary Figure 2). This 
parallelisation allowed processing the 1,239 MANOLIS samples in under 
a month, and as imputation software continue to grow more efficient (By-
croft, et al., 2017), future pipelines should greatly simplify postprocessing 
of very low depth sequencing data.  
 
As a proof of principle, we used imputed GWAS, 1x and 22x WGS in 
overlapping samples from an isolated population to assess how genotyp-
ing quality influences power in association studies. As we only wanted to 
study the implications of varying genotype qualities afforded by different 
designs on association p-values in a discovery setting, we considered only 
suggestively associated signals and did not seek replication in a larger co-
horts for the discovered signals. In our study of 57 quantitative traits, we 
show that an 1x-based design allows the discovery of twice as many of the 
signals suggestively associated in the more accurate 22x WGS study, com-
pared to the imputed GWAS design. Almost 10% of the suggestive signals 
arising in the 1x data are not discoverable in the imputed GWAS, but the 
great majority (96%) of imputed GWAS signals is found using the 1x.  
 
The 1x-based study seems to discover more signals than the imputed 
GWAS across the MAF spectrum, and this remains true whether or not 
the signals are filtered for suggestive association p-value in the more ac-
curate 22x based study (Supplementary Table 3). At first glance this sug-
gests 1x WGS has better detection power than the imputed GWAS across 
the MAF spectrum, however it is unlikely that this is true for common 
variants, which are reliably imputed using chip data. Instead, this phenom-
enon may be due to a slightly less accurate imputation than in the GWAS 
dataset caused by a noisier raw genotype input (Supplementary Text). This 
effect is marginal, as evidenced by genome-wide concordance measures 
(Figure 2) which are very high at the common end of the MAF spectrum. 
However, it is important to note that this slightly less accurate imputation 
can attenuate some signals as well as boosting others. For this reason, we 
would recommend relaxing the discovery significance threshold in 1x 
studies in order to capture those less well imputed, signal-harbouring var-
iants, followed by rigorous replication in larger cohorts and direct valida-
tion of genotypes.  
 
Our study's intent was to focus on the performance on commonly used 
general-purpose tools for low-depth sequencing data in isolates, both for 
genotype calling (GATK) and imputation (BEAGLE, IMPUTE). There 
are ongoing efforts to leverage the specificities of both low-depth 
b.
a.
Figure 5: Association signals in the 1x WGS and imputed GWAS at  p<5x10-7 for 57 
quantitative traits in the 1,225 samples with both imputed GWAS and low-depth 
WGS. Purple dots represent significant results in the imputed GWAS (a.) and the 1x WGS 
(b.) analysis. Orange dots, if present, denote the p-value of the same SNP in the other study. 
Blue dots represent the association p-value in a larger (n=1,457) association study based on 
22x WGS. Signals with a 22x WGS p-value above 5x10-5 were considered as false positives 
in both studies and excluded from the plot. Red dashes indicate the minimum p-value 
among all tagging SNVs in the other dataset (r2>0.8). Absence of an orange dot and/or a 
red dash means that the variant was not present and/or no tagging variant could be found 
for that signal in the other study.  
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sequencing (Davies, et al., 2016)(https://www.gencove.com) and of iso-
lated populations (Livne, et al., 2015). The popularity and long-term sup-
port of established generic methods is an advantage when running com-
plex study designs, as has been shown in other isolate studies (Herzig, et 
al., 2018). This study focused on SNVs, excluding INDELS due to high 
expected noise levels, poor call rate and genotype accuracy, as well as 
lower imputation quality using general-purpose tools. Very low depth 
based studies rely heavily on imputation to complete the sparse picture of 
variation painted by few and far between reads. The accurate detection and 
genotyping of larger variants such as structural variants (SV), which relies 
more heavily on read-based evidence such as split reads, insert size or 
depth anomalies, and which are currently poorly imputed, is therefore 
likely to remain a methodological challenge for low-depth WGS studies. 
 
We show that very low depth whole-genome sequencing allows the accu-
rate assessment of most common and low-frequency variants captured by 
imputed GWAS designs and achieves denser coverage of the low-fre-
quency and rare end of the allelic spectrum, albeit at an increased compu-
tational cost. This allows very low depth sequencing studies to recapitulate 
signals discovered by imputed chip-based efforts, and to discover signifi-
cantly associated variants missed by GWAS imputation (Gilly, et al., 
2016).  Although cohort-wide high-depth WGS remains the gold standard 
for the study of rare and low-frequency variation, very low-depth WGS 
designs using population-specific haplotypes for imputation remain a via-
ble alternative when studying populations poorly represented in existing 
large reference panels. 
4 Methods 
4.1 Cohort details 
The HELIC (Hellenic Isolated Cohorts; www.helic.org) MANOLIS (Mi-
noan Isolates) collection focuses on Anogia and surrounding Mylopota-
mos villages on the Greek island of Crete. All individuals were required 
to have at least one parent from the Mylopotamos area to enter the study. 
Recruitment was primarily carried out at the village medical centres. The 
study includes biological sample collection for DNA extraction and lab-
based blood measurements, and interview-based questionnaire filling. The 
phenotypes collected include anthropometric and biometric measure-
ments, clinical evaluation data, biochemical and haematological profiles, 
self-reported medical history, demographic, socioeconomic and lifestyle 
information. The study was approved by the Harokopio University Bio-
ethics Committee and informed consent was obtained from every partici-
pant. 
4.2 Sequencing  
Sequencing and mapping for the 990 MANOLIS samples at 1x depth has 
been described previously (Gilly, et al., 2016), as well as for 249 
MANOLIS samples at 4x (Southam, et al., 2017), and for 1,457 samples 
at 22x (Gilly, et al., 2018). For comparison, 5 samples from the cohort 
were also whole-exome sequenced at an average depth of 75x. We use a 
standard read alignment and variant calling pipeline using samtools(Li, et 
al., 2009) and GATK(McKenna, et al., 2010), which is described in detail 
in the Supplementary Text. A Venn diagram detailing the overlap between 
the sequenced and genotyped datasets is given in Supplementary Figure 3. 
4.3 Variant filtering 
Variant quality score recalibration was performed using GATK VQSR 
v.3.1.1. However, using the default parameters for the VQSR mixture 
model yields poor filtering, with a Ti/Tv ratio dropoff at 83% percent sen-
sitivity and a Ti/Tv ratio of 1.8 for high-quality tranches (Supplementary 
Figure 4.a). We therefore ran exploratory runs of VQSR across a range of 
values for the model parameters, using the dropoff point of the transi-
tion/transversion (Ti/Tv) ratio below 2.0 as an indicator of good fit (Sup-
plementary Figure 5). A small number of configurations outperformed all 
others, which allowed us to select an optimal set of parameters. For the 
chosen set of parameters, false positive rate is estimated at 10%±5% (Sup-
plementary Figure 4.b). Indels were excluded from the dataset out of con-
cerns for genotype quality. We found that the version of VQSR, as well as 
the annotations used to train the model, had a strong influence on the qual-
ity of the recalibration (Supplementary Figure 5 and Supplementary Text). 
4.4 Comparison with downsampled whole genomes 
For quality control purposes, reads from 17 of the well-characterised Plat-
inum Genomes sequenced by Illumina at 50x depth (Eberle, et al., 2017), 
and downsampled to 1x depth using samtools (Li, et al., 2009) were in-
cluded in the merged BAM file. VQSR-filtered calls were then compared 
to the high-confidence call sets made available by Illumina for those sam-
ples. 524,331 of the 4,348,092 non-monomorphic variant sites were not 
present in the high-confidence calls, whereas 1,246,403 of the 5,070,164 
non-monomorphic high-confidence were not recapitulated in the 1x data. 
This corresponds to an estimated false positive rate of 12% and false neg-
ative rate of 24.6%. Both unique sets had a much higher proportion of 
singletons (corresponding to MAF < 2.9%) than the entire sets (57.9% vs 
19.9% of singletons among 1x calls and 51% vs 18.1% among high-con-
fidence calls), which suggests that a large fraction of the erroneous sites 
lies in the low-frequency and rare part of the allelic spectrum. However, 
genotype accuracy is poor, to the point where it obscures peculiarities in 
the distribution of allele counts (Supplementary Figure 6). Due to these 
being present in the 1000 genomes reference panel, we remove the 17 
Platinum Genomes prior to imputation. 
4.5 Genotype refinement and imputation 
Evaluation of pipelines 
The authors of SHAPEIT (Delaneau, et al., 2013) advise to phase whole 
chromosome when performing pre-phasing in order to preserve down-
stream imputation quality.  This approach is computationally intractable 
for the 1x datasets, where the smallest chromosomes contain almost 7 
times more variants than the largest chromosomes in a GWAS dataset.  
 
For benchmarking purposes, we designed 13 genotype refinement pipe-
lines involving Beagle v4.0 (Browning and Browning, 2007) and 
IMPUTE2 (Howie, et al., 2011; Howie, et al., 2009) using a 1000 Ge-
nomes phase 1 reference panel, which we evaluated against minor allele 
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concordance. All pipelines were run using the vr-runner scripts 
(https://github.com/VertebrateResequencing/vr-runner). Pipelines involv-
ing Beagle with the use of a reference panel ranked consistently better 
(Supplementary Figure 1), with a single run of reference-based refinement 
using Beagle outperforming all other runs. IMPUTE2 performed worst on 
its own, whether with or without reference panel; in fact the addition of a 
reference panel did not improve genotype quality massively. Phasing with 
Beagle without an imputation panel improved genotype quality, before or 
after IMPUTE2. 
 
Halving the number of SNVs per refinement chunk (including 500 flank-
ing positions) from the 4,000 recommended by the vr pipelines resulted in 
only a modest loss of genotype quality in the rare part of the allelic spec-
trum (Supplementary Figure 7), while allowing for a twofold increase in 
refinement speed. Genotype quality dropped noticeably for rare variants 
when imputation was turned on (Supplementary Figure 7), but remained 
high for low-frequency and common ones. A reference-free run of Beagle 
allowed to phase all positions and remove genotype missingness with no 
major impact on quality and a low computational cost. We initially also 
tested thunderVCF (https://genome.sph.umich.edu/wiki/ThunderVCF) 
for phasing sites, however, the program took more than 2 days to run on 
5,000 SNV chunks and was abandoned. 
Production pipeline for the MANOLIS cohort 
For production, we used a previously-described (Southam, et al., 2017) 
reference panel composed of 10,244 haplotypes from the 1000 Genomes 
Project Phase 1 (n=1,092), 249 MANOLIS samples sequenced at 4x 
depth, as well as the two cohorts included in the UK10K study (UK10K 
Consortium, et al., 2015) (TwinsUK (Moayyeri, et al., 2013) and 
ALSPAC (Golding, et al., 2001) (total n=3,781, 7x WGS)). Alleles in the 
reference panel were matched to the reference allele in the called dataset. 
Positions where the alleles differed between the called and reference da-
tasets were removed from both sources. Indels were filtered out due to 
poor calling quality.  
 
The pipeline with best minor allele concordance across the board used 
Beagle v.4 (Browning and Browning, 2007) to perform a first round of 
imputation-based genotype refinement on 1,239 HELIC MANOLIS vari-
ant callsets, using the aforementioned reference panel. This was followed 
by a second round of reference-free imputation, using the same software.  
 
Variant-level QC 
Beagle provides two position level imputation metrics, allelic R-squared 
(AR2) and dosage R-squared (DR2). Both measures are highly correlated 
(Supplementary Figure 8.a). Values between 0.3 and 0.8 are typically used 
for filtering (Brian Browning, personal communication). In the 1x dataset 
59% and 91% of imputed variants lie below those two thresholds, respec-
tively. The distribution of scores does not provide an obvious filtering 
threshold (Supplementary Figure 8.b) due to its concavity. Since most im-
puted variants are rare and R-squared measures are highly correlated with 
MAF, filtering by AR2 and DR2 would be similar to imposing a MAF 
threshold (Supplementary Figure 8.c and d.). Moreover, due to a technical 
limitation of the vr-runner pipelines, imputation quality measures were not 
available for refined positions at the time of analysis, only imputed ones. 
Therefore, we did not apply any prior filter in downstream analyses. 
 
4.6 Sample QC 
Due to the sparseness of the 1x datasets, sample-level QC was performed 
after imputation. 5 samples were excluded from the MANOLIS 1x cohort 
following PCA-based ethnicity checks.  
4.7 Comparison with WES 
A set of high confidence genotypes was generated for the 5 exomes in 
MANOLIS using filters for variant quality (QUAL>200), call rate 
(AN=10, 100%) and depth (250x). These filters were derived from the re-
spective distributions of quality metrics (Supplementary Figure 9).  
When compared to 5 whole-exome sequences from the MANOLIS cohort, 
imputed 1x calls recapitulated 77.2% of non-monomorphic, high-quality 
exome sequencing calls. Concordance was high, with only 3.5% of the 
overlapping positions exhibiting some form of allelic mismatch. When re-
stricting the analysis to singletons, 9105 (58%) of the 15,626 high-quality 
singletons in the exomes were captured, with 21% of the captured posi-
tions exhibiting false positive genotypes (AC>1). To assess false positive 
call rate, we extracted 1x variants falling within the 71,627 regions tar-
geted by the Agilent design file for WES in overlapping samples, and com-
pared them to those present in the unfiltered WES dataset. 103,717 vari-
ants were called in these regions from WES sequences, compared to 
58,666 non-monomorphic positions in the 1x calls. 1,419 (2.4%) of these 
positions were unique to the 1x dataset, indicating a low false-positive rate 
in exonic regions post-imputation.  
4.8 Genetic relatedness matrix 
Relatedness was present at high levels in our cohort, with 99.5% of sam-
ples having at least one close relative (estimated  𝜋" > 0.1) and an average 
number of close relatives of 7.8. In order to correct for this close kinship 
typical of isolated cohorts, we calculated a genetic relatedness matrix us-
ing GEMMA (Zhou and Stephens, 2012). Given the isolated nature of the 
population and the specificities of the sequencing dataset, we used differ-
ent variant sets to calculate kinship coefficients. Using the unfiltered 1x 
variant dataset produced the lowest coefficients (Figure 10.a), whereas 
well-behaved set of common SNVs (Arthur, et al., 2017) produced the 
highest, with an average difference of 3.67x10-3. Filtering for MAF in-
creased the inferred kinship coefficients. Generally, the more a variant set 
was sparse and enriched in common variants, the higher the coefficients 
were. However, these differences only had a marginal impact on associa-
tion statistics, as evidenced by a lambda median statistic difference of 0.02 
between the two most extreme estimates of relatedness when used for a 
genome-wide association of triglycerides (Supplementary Figure 10.b). 
For our association study, we used LD-pruned 1x variants filtered for 
MAF<1% and Hardy Weinberg equilibrium p<1x10-5 to calculate the re-
latedness matrix, which translated into 2,848,245 variants for MANOLIS. 
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4.9 Single-point association 
Pipeline 
For association, fifty-seven phenotypes were prepared, with full details of 
the trait transformation, filters and exclusions described in Supplementary 
Table 4. The ‘transformPhenotype’ (https://github.com/wtsi-
team144/transformPhenotype) R script was used to apply a standardised 
preparation for all phenotypes. Association analysis was performed using 
the linear mixed model implemented in GEMMA (Zhou and Stephens, 
2012) on all variants with minor allele count (MAC) greater than 2 
(14,948,665 out of 30,483,158 variants in MANOLIS). Singletons and 
doubletons are removed due to overall low minor allele concordance. We 
used the aforementioned centered kinship matrix. GC-corrected p-values 
from the score test (p_score) were used due to residual inflation being pre-
sent in some traits. Signals were extracted using the peakplotter software 
(https://github.com/wtsi-team144/peakplotter ) using a window size of 
1Mb. 
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